Try our corporate solution for free!
+1 (212) 419-5770

Novel pain drug clinical trials success rates U.S. 2006-2015, by phase

This statistic depicts the success rates of novel pain medication clinical trials in the U.S. between 2006 and 2015, by phase. According to the data, just two percent of NMEs (new molecular entities) were successful between phase I and approval during that time.

Success rates of novel pain drug clinical trials in the U.S. between 2006 and 2015, by phase

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date



United States

Survey time period

2006 to 2015

Supplementary notes

NDA/BLA = new drug application/biologic license application
NME = new molecular entity

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Clinical trials"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.